Tranche Update on i-SENS, Inc.'s Equity Buyback Plan announced on August 20, 2018.
February 19, 2019 at 10:41 am IST
Share
From August 20, 2018 to September 30, 2018, the company has repurchased 69,000 shares, representing 0.5% for KRW 1,506.19 million. With this, the company has completed the repurchase of 69,000 shares, representing 0.5% for KRW 1,506.19 million under the buyback announced on August 20, 2018.
i-SENS, Inc. is a Korea-based company mainly engaged in the manufacture and sale of biosensors. The Companyâs products consist of blood glucose monitoring systems, including blood glucose monitors, blood glucose meters, glucose monitors, blood glucose meter kits and blood sugar meters under the brand names of CareSens, MedTrust, BGStar, Barozen and others; electrolyte analyzers and cartridges; immunosensors, as well as other related accessories, such as connectors, lancets, blood glucose data management software and lancing devices, among others. The Company distributes its products within domestic market and to overseas markets including Japan, Europe, the United States and others.
I-SENS, INC. 
